Life sciences news
-
AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies
Wednesday December 2nd 2020
Read more
-
atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer
Tuesday December 1st 2020
Read more
-
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
Tuesday December 1st 2020
Read more
-
Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers
Tuesday December 1st 2020
Read more
-
Mithra's exclusivity on Estetrol applications extended to 2036 in Europe
Tuesday December 1st 2020
Read more
-
flanders.bio job board increasingly popular
Thursday November 26th 2020
Read more
-
Estetrol recognized as a "New Active Substance" by the European Medicines Agency (EMA)
Wednesday November 25th 2020
Read more
-
Novalis Biotech announces first closing of its second healthcare fund
Tuesday November 24th 2020
Read more
-
Become a flanders.bio member
Your news here?
-
Selvita to acquire Fidelta from Galapagos
Tuesday November 24th 2020
Read more
-
Qarad opent nieuw kantoor in VK
Tuesday November 24th 2020
Read more
-
argenx enters into agreement to acquire Priority Review Voucher
Monday November 23rd 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
